PubMed HealthSearch

Biomedical subjects

G Offer

Publications and source records attributed to G Offer.

15 recordsLinked to original sources

Skip residues correlate with bends in the myosin tail.

Sharp bends have previously been observed in the tail of the skeletal myosin molecule at well-defined positions 44, 75 and 135 nm from the head-tail junction, and in vertebrate smooth myosin at two positions about 45 and 96 nm from this junction. The amino acid sequence of the heavy chain does not straightforwardly account for such bending on the original model of the tail in which an invariant proline residue is present at the head-tail junction and the repeating seven amino acid pattern of hydrophobic residues lies entirely in the tail. Recently, a revised model has been proposed by Rimm et al. in which the first seven to eight heptads lie in the heads. It is shown here that with this model the observed bends in the tail of skeletal myosin coincide with three of the four additional (skip) residues that interrupt the heptad repeat. It is concluded that the skip residues, by causing localized instability of the coiled-coil, are responsible for the bends. Smooth myosin lacks the second of these skip residues explaining the absence of a bend at 75 nm.

Amino Acid Sequence

Phosphofructokinase: a component of the thick filament?

F-protein, a consistent contaminant of myosin preparations, has been shown to be phosphofructokinase, the key regulatory enzyme of glycolysis. In homogenates of rigor muscle most of the phosphofructokinase sediments with the myofibrils, suggesting that in the living muscle cell phosphofructokinase is not in the soluble fraction as was formerly thought, but bound to the myofibrils. Fluorescent antibody to F-protein labels myofibrils in a zone in each half of the A-band. The increase in separation of the zones across the A-band with increase in sarcomere length suggests that the antibody binds to the parts of the cross-bridge regions of the thick filament within the H-zone. It therefore seems likely that phosphofructokinase is located in the cross-bridge region of the thick filament, but that access of antibody is restricted by overlapping thin filaments.

Animals

p-NN'-phenylenebismaleimide, a specific cross-linking agent for F-actin.

Covalent cross-links can be inserted between the subunits of F-actin by using p-NN'-phenylenebismaleimide. Cross-linking reaches its maximum value when one molecule of reagent has reacted with each actin subunit. p-NN'-Phenylenebismaleimide reacts initially with a cysteine residue on one subunit, the slower cross-linking reaction involving a lysine residue on a neighbouring subunit. Hydrolysis of the actin-bound reagent limits the extent of cross-linking. Quantitative analysis of the amounts of cross-linked oligomers seen on polyacrylamide gels containing sodium dodecyl sulphate suggests that neither the binding of the reagent to actin nor the formation of cross-links introduces strain into the structure. The cross-links do not join together different F-actin filaments, and evidence is presented that suggests that the cross-links join subunits of the same long-pitched helix.

Actins

The interaction of C-protein with heavy meromyosin and subfragment-2.

C-protein has previously been shown to bind to the light-meromyosin region of the myosin tail. Examination of mixtures of C-protein with heavy meromyosin or subfragment-2 or subfragment-1 in the analytical ultracentrifuge shows that there is also a binding site for C-protein in the subfragment-2 region of the tail.

Binding Sites

Can a myosin molecule bind to two actin filaments?

It is suggested that in striated muscles the two heads of one myosin molecule are able to interact with different actin filaments. This would provide a simple explanation for the appearance and arrangement of cross-bridges in insect flight muscle in rigor.

Actins

[Hashimoto's thyroiditis. Clinical contribution].

--After a brief account of anatomical and clinical findings of Hashimoto's thyroiditis, 8 cases, personally observed, are presented. The various aspects of this disease and in particular the most recent diagnostic methods are examined and therapeutical possibilities, from the medical and surgical standpoint, are discussed.

Adolescent